Barclays upgraded CVS Health Inc (NYSE:CVS) on higher Pharmacy & Consumer Wellness (PCW) estimates as headwinds are offset by ...

Stock in the healthcare provider Humana came under pressure again on Friday after the U.S. government released quality ...

The U.S. government announced quality ratings for 2025 Medicare health and prescription drug plans on Thursday, the first ...

The layoffs are part of CVS’ plans, announced last week, for slashing 2,900 corporate jobs nationwide, as it seeks to cut $2 ...

CVS Health (CVS) stock gained as Barclays upgraded the company, citing a compelling path to margin recovery in its Medicare ...

CVS Health is laying off nearly 3,000 "primarily corporate roles" in a cost-cutting move, the company confirmed to USA TODAY ...

Profitability pressures are expected to continue, driven by CVS Health's Insurance business. Read more to see why CVS stock ...

CVS Health and Cigna on Tuesday released details on their government-backed health insurance plans for next year for people ...

Analysts at TD Cowen have raised their rating of CVS Health (NYSE:CVS) to "Buy" from "Hold", citing changes to its 2025 Medicare Advantage plan benefits announced earlier this week.

Talk that CVS Health may break up its businesses would mean unraveling synergies already making the company a lot of money.

Discover why TD Cowen sees 35% upside in CVS Health stock, driven by Medicare Advantage improvements and bullish technical ...

Glenview Capital Management — a hedge fund that has been subject of certain media reports that it was pushing CVS Health ...